The Department of Health and Human Services Food and Drug Administration awarded a $20,501 purchase order to Altair Engineering Inc. Headquarters Division for electromagnetic modeling and simulation software with a 12-month warranty. Altair will provide its electromagnetic modeling and simulation software to support the FDA's work. Performance will take place in Silver Spring, Maryland under a firm fixed price contract running from August 18, 2023 through August 17, 2024. No subcontractors or...
This federal contract award, valued at $145,258.40, was issued by the Food and Drug Administration (FDA) to Altair Engineering Inc., a global leader in computational science and artificial intelligence software. The contract focuses on addressing the risks and challenges associated with allowing patients with implantable medical devices to undergo MRI examinations, such as potential heating, burn, mechanical force, torque, and vibrations that can be extremely dangerous to patients. Altair...
The Food and Drug Administration (FDA) awarded a $107,856.04 firm-fixed-price purchase order to Anylogic North America, LLC for AnyLogic simulation modeling software licenses and maintenance services. The sole source award does not have a set-aside designation. The award supports the FDA's Center for Devices and Radiological Health (CDRH) in simulating business processes and assessing resource requirements. AnyLogic provides discrete event, agent-based, and system dynamics modeling...
The U.S. Department of Health and Human Services Food and Drug Administration awarded a delivery order to Ansys Inc., a provider of engineering simulation software, for a "Shared Multiphysics Computational Modeling Platform." The $137,297.23 firm-fixed-price contract, which does not have a set-aside designation, was issued under Ansys' existing Multiple Award Schedule (MAS) contract with the General Services Administration. This 5-year, $558 million IDIQ vehicle allows federal agencies...
This is a firm-fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Ansys Inc., a provider of engineering simulation software and services. The contract, valued at $121,691.93, is for the provision of computational fluid dynamics (CFD) modeling software and does not have a set-aside designation. The contract was issued under Ansys' General Services Administration (GSA) Federal Supply Schedule IT-70 contract, a $558 million IDIQ vehicle that enables federal agencies...
The U.S. Food and Drug Administration (FDA) awarded a firm fixed price purchase order contract worth $106,055.00 to Siemens Industry Software Inc., doing business as Siemens PLM Software, for a new license of the company's gPROMS or equal flowsheet modeling and simulation software. The software will be used to study emerging pharmaceutical manufacturing technologies and includes capabilities for steady-state and dynamic process modeling, parameter estimation, and optimization across a range of...
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Altair Engineering Inc., a global leader in computational science and artificial intelligence software. The $78,000.00 contract is for the procurement of HyperWorks software, which supports computational fluid dynamics, finite element analysis, and other high-performance engineering applications. The award was made on a sole-source basis due to compatibility and continuity requirements,...
The Department of Health and Human Services, Food and Drug Administration awarded a fixed-price purchase order contract to Certara USA Inc., doing business as Tripos (De), for an annual Phoenix Quantum software subscription. The contract, with a potential value of $216,547.78, provides the FDA's Office of Clinical Pharmacology with the necessary modeling and simulation tools to analyze and verify sponsor submissions, including Investigational New Drug, New Drug, Biologics Licensing, and...
This firm-fixed-price purchase order awards Simulations Plus Inc., doing business as Simulations Plus, a contract valued at $375,965.05 to provide software licenses for GastroPlus, DDDPlus, and MembranePlus to the Food and Drug Administration (FDA). These software products are used for physiologically-based pharmacokinetic (PBPK) modeling, predicting drug absorption and pharmacokinetics, and conducting virtual bioequivalence studies to support pharmaceutical research, development, and regulatory...
The U.S. Food and Drug Administration (FDA) awarded a firm fixed price purchase order to Certara UK Limited, doing business as Certara, a for-profit limited liability company, for SIMCYP software licenses and maintenance support. The $114,316.00 contract will allow the FDA's Office of Clinical Pharmacology Drug Reviewers to complete their review of investigational new drugs. Certara has previously provided this physiologically-based pharmacokinetic modeling software to the FDA and...